D’Angelo, S.; Tirri, E.; Giardino, A.M.; Mattucci-Cerinic, M.; Dagna, L.; Santo, L.; Ciccia, F.; Frediani, B.; Govoni, M.; Bobbio Pallavicini, F.;
et al. Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study. J. Clin. Med. 2022, 11, 4178.
https://doi.org/10.3390/jcm11144178
AMA Style
D’Angelo S, Tirri E, Giardino AM, Mattucci-Cerinic M, Dagna L, Santo L, Ciccia F, Frediani B, Govoni M, Bobbio Pallavicini F,
et al. Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study. Journal of Clinical Medicine. 2022; 11(14):4178.
https://doi.org/10.3390/jcm11144178
Chicago/Turabian Style
D’Angelo, Salvatore, Enrico Tirri, Angela Maria Giardino, Marco Mattucci-Cerinic, Lorenzo Dagna, Leonardo Santo, Francesco Ciccia, Bruno Frediani, Marcello Govoni, Francesca Bobbio Pallavicini,
and et al. 2022. "Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study" Journal of Clinical Medicine 11, no. 14: 4178.
https://doi.org/10.3390/jcm11144178
APA Style
D’Angelo, S., Tirri, E., Giardino, A. M., Mattucci-Cerinic, M., Dagna, L., Santo, L., Ciccia, F., Frediani, B., Govoni, M., Bobbio Pallavicini, F., Grembiale, R. D., Delle Sedie, A., Mulè, R., Cantatore, F. P., Foti, R., Gremese, E., Conigliaro, P., Salaffi, F., Viapiana, O.,
... Iannone, F.
(2022). Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study. Journal of Clinical Medicine, 11(14), 4178.
https://doi.org/10.3390/jcm11144178
